Xavier Rubiralta

Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain.

Werfen NV is a Belgian company that unites its subsidiaries, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, under one brand name, Werfen. The private company is based in Zaventem, Belgium. The company has completed organizational transitions and adopted a new brand identity, including a new corporate logo. Werfen has been known as Werfen outside of Belgium since 2014. Werfen was founded in 1966, and the CEO is Carlos Pascual.

Werfen NV is a Belgian company that unites its subsidiaries, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, under one brand name, Werfen. The private company is based in Zaventem, Belgium. The company has completed organizational transitions and adopted a new brand identity, including a new corporate logo. Werfen has been known as Werfen outside of Belgium since 2014. Werfen was founded in 1966, and the CEO is Carlos Pascual.

Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain.

Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain.

Werfen NV is a Belgian company that unites its subsidiaries, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, under one brand name, Werfen. The private company is based in Zaventem, Belgium. The company has completed organizational transitions and adopted a new brand identity, including a new corporate logo. Werfen has been known as Werfen outside of Belgium since 2014. Werfen was founded in 1966, and the CEO is Carlos Pascual.

Werfen NV is a Belgian company that unites its subsidiaries, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, under one brand name, Werfen. The private company is based in Zaventem, Belgium. The company has completed organizational transitions and adopted a new brand identity, including a new corporate logo. Werfen has been known as Werfen outside of Belgium since 2014. Werfen was founded in 1966, and the CEO is Carlos Pascual.

Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain.

Werfen NV is a Belgian company that unites its subsidiaries, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, under one brand name, Werfen. The private company is based in Zaventem, Belgium. The company has completed organizational transitions and adopted a new brand identity, including a new corporate logo. Werfen has been known as Werfen outside of Belgium since 2014. Werfen was founded in 1966, and the CEO is Carlos Pascual.

Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain.

Werfen NV is a Belgian company that unites its subsidiaries, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, under one brand name, Werfen. The private company is based in Zaventem, Belgium. The company has completed organizational transitions and adopted a new brand identity, including a new corporate logo. Werfen has been known as Werfen outside of Belgium since 2014. Werfen was founded in 1966, and the CEO is Carlos Pascual.

Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain.

Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain.

Werfen NV is a Belgian company that unites its subsidiaries, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, under one brand name, Werfen. The private company is based in Zaventem, Belgium. The company has completed organizational transitions and adopted a new brand identity, including a new corporate logo. Werfen has been known as Werfen outside of Belgium since 2014. Werfen was founded in 1966, and the CEO is Carlos Pascual.

Werfen NV is a Belgian company that unites its subsidiaries, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, under one brand name, Werfen. The private company is based in Zaventem, Belgium. The company has completed organizational transitions and adopted a new brand identity, including a new corporate logo. Werfen has been known as Werfen outside of Belgium since 2014. Werfen was founded in 1966, and the CEO is Carlos Pascual.